These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36252259)

  • 21. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimations of overdiagnosis in breast cancer screening vary between 0% and over 50%: why?
    Chaltiel D; Hill C
    BMJ Open; 2021 Jun; 11(6):e046353. PubMed ID: 34158298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overdiagnosis associated with breast cancer screening: A simulation study to compare lead-time adjustment methods.
    Seigneurin A; Labarère J; Duffy SW; Colonna M
    Cancer Epidemiol; 2015 Dec; 39(6):1128-35. PubMed ID: 26341587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of Overdiagnosis: Impact on Screening Mammography Practices.
    Morris E; Feig SA; Drexler M; Lehman C
    Popul Health Manag; 2015 Sep; 18 Suppl 1(Suppl 1):S3-11. PubMed ID: 26414384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of overdiagnosis in breast cancer screening using a non-homogeneous multi-state model: A simulation study.
    Wu WY; Nyström L; Jonsson H
    J Med Screen; 2018 Dec; 25(4):183-190. PubMed ID: 29153013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
    Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H
    Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.
    Michalopoulos D; Duffy SW
    J Med Screen; 2016 Dec; 23(4):192-202. PubMed ID: 26940963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States.
    Zahl PH; Jørgensen KJ
    Ann Intern Med; 2024 Mar; 177(3):403. PubMed ID: 38498895
    [No Abstract]   [Full Text] [Related]  

  • 29. Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States.
    Richman IB; Gross CP
    Ann Intern Med; 2024 Mar; 177(3):403-404. PubMed ID: 38498894
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer.
    van Luijt PA; Rozemeijer K; Naber SK; Heijnsdijk EA; van Rosmalen J; van Ballegooijen M; de Koning HJ
    J Med Screen; 2016 Dec; 23(4):210-216. PubMed ID: 27068430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Discrepancies and overdiagnosis in breast cancer organized screening. A "methodology" systematic review].
    Gocko X; Leclerq M; Plotton C
    Rev Epidemiol Sante Publique; 2018 Nov; 66(6):395-403. PubMed ID: 30316554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overdiagnosis in the Age of Digital Cancer Screening.
    Brawley OW; Paller CJ
    J Natl Cancer Inst; 2021 Jan; 113(1):1-2. PubMed ID: 32572471
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term relationships between screening rates, breast cancer characteristics, and overdiagnosis in US counties, 1975-2009.
    Harding C; Pompei F; Burmistrov D; Wilson R
    Int J Cancer; 2019 Feb; 144(3):476-488. PubMed ID: 30264887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
    Nelson HD; Pappas M; Cantor A; Griffin J; Daeges M; Humphrey L
    Ann Intern Med; 2016 Feb; 164(4):256-67. PubMed ID: 26756737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast Cancer Screening Frequency and Overdiagnosis.
    Ponti A; Frigerio A; Marra V; Armaroli P; Segnan N
    J Am Coll Radiol; 2017 Dec; 14(12):1520. PubMed ID: 29202932
    [No Abstract]   [Full Text] [Related]  

  • 36. Recognizing the Limitations of Cancer Overdiagnosis Studies: A First Step Towards Overcoming Them.
    Etzioni R; Gulati R
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26582245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Screening Illustrator: separating the effects of lead-time and overdiagnosis in mammography screening.
    Lousdal ML; Møller MH; Kristiansen IS; Kalager M; Wisløff T; Støvring H
    Eur J Public Health; 2018 Dec; 28(6):1138-1142. PubMed ID: 29796623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. As you like it: How the same data can support manifold views of overdiagnosis in breast cancer screening.
    Njor SH; Paci E; Rebolj M
    Int J Cancer; 2018 Sep; 143(6):1287-1294. PubMed ID: 29633249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
    Coldman A; Phillips N
    CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?
    Rahbar H; McDonald ES; Lee JM; Partridge SC; Lee CI
    Acad Radiol; 2016 Jun; 23(6):768-73. PubMed ID: 27017136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.